Health care

Competition Problems in Prescription Drug Market

Although not the sole cause of high prescription drug costs, abusive practices that distort competition contribute to the problem. Too many companies...

The Unchecked Market Power of the American Health Care System

Chicago Booth alumnus and retired health care consultant David W. Ennis responds to ProMarket’s recent coverage on antitrust and the US health...

The Covid-19 Pandemic Should Not Delay Actions to Prevent Anticompetitive Consolidation in US Health Care Markets

Harvard Business School professor Leemore Dafny lays out potential reforms to assist agencies in halting anticompetitive acquisitions and practices, and to preserve...

More Than 20 Years of Consolidation Have Led to a Dysfunctional Health Care Market

The US health care system is based on markets, which do not function as well as they could, or should. Prices are...

Preventing Drug Shortages and Saving Lives: The Role of Quality and Reliability Standards

Prescription drug shortages have become more common in recent years, interrupting usual medical care and increasing patient risk and system costs, but...

How the FTC Protected the Market Power of Pharmacy Benefit Managers

Pharmacy Benefit Managers (PBMs) were established in the 1960s to control drug costs but have since morphed into one of the most...

What Is the Price of a Prescription Drug?

Due to lack of transparency and mystery rebates, which are considered trade secrets, figuring out the price of a prescription drug is...

“The Antitrust Doctrine We’ve Seen Over the Last 40 Years Simply Does Not Match the Lived Experience of People”

In an interview with ProMarket, investigative journalist David Dayen discusses the toll that monopoly power takes on the lives of ordinary Americans...

Why We Should Be Careful About Google’s Promises in the Fitbit Deal

Google claims its acquisition of Fitbit is not about data, but hardware. This is simply not credible. Data plays a crucial role...

Covid Economics: The Marcoeconomic Impact of the Pandemic and Policy Responses

ProMarket reviews the most recent and interesting academic papers on the ongoing pandemic: One paper argues that people do not always fully internalize the...

LATEST NEWS

How Will the FTC Evaluate Vertical Mergers?

The Federal Trade Commission’s recent withdrawal of its 2020 vertical merger guidelines is flatly incorrect as a matter of microeconomic theory and...

Announcing the Participants in the Fall 2021 Stigler Center Journalists in Residence Program

This month, the Stigler Center will welcome eight world-class journalists from the United Kingdom, Brazil, China, Romania, Ukraine, Slovenia, and the United...

The Roots of America’s Competition Revolution

Proponents of the current transformation in America’s competition policy managed to shape legislative reform proposals, push public antitrust agencies to boost enforcement, and successfully...

Looks Can Be Deceiving: Ronald Coase and the Chicago School

Ronald Coase is typically thought of as one of the Chicago School’s brightest lights. But Coase’s relationship with Chicago was always an...

A New Browser Extension Aims to Bring Transparency to Big Tech Funding

As Congress prepares to debate a series of new antitrust bills​, the​ Big Tech Funding browser extension encourages lawmakers to be mindful...